Glucose control: When dapagliflozin is taken along with other medications for diabetes, glucose levels may drop too far, causing confusion, cold sweats, cool and pale skin, headache, fast heartbeat, or weakness. Your doctor may suggest decreasing the dose of your other medications when you first start taking dapagliflozin. If you take other medications for diabetes, discuss with your doctor how this medication may affect your medical condition, how your medical condition may affect the dosing and effectiveness of this medication, and whether any special monitoring is needed.
As reported in recent bodybuilding publications and media, Nandrolone Decanoate can be used carefully by women as a supplement for fitness models as well as athletes, which is rare with steroids producing any kind of androgenic side effects. Recommended doses for women are much lower, typically around 50 mg/ week. The drug’s popularity among fitness models as well as athletes puts Nandrolone Decanoate on the red carpet walk for certain. News reports say that precautions must be taken when used by women, as adverse side effects affect some individuals while producing no adverse side effects for others. Results for men are fairly concrete, but results for women using hormonally based supplements do vary, so according to media sources, women athletes and bodybuilders should use this product with caution and start with very small doses.
1) For Patients Not Currently Treated with an erythropoiesis-stimulating agent (ESA):
Initial dose: mcg/kg body weight administered as a single IV or subcutaneous injection once every two weeks
Epoetin beta-methoxy polyethylene glycol should be dosed to achieve and maintain hemoglobin between 10 and 12 g/dL. Once the hemoglobin has been maintained within this range, epoetin beta-methoxy polyethylene glycol may be administered once monthly using a dose that is twice that of the every two week dose and subsequently titrated as necessary.
2) For Patients Currently Treated with an erythropoiesis-stimulating agent (ESA):
Epoetin beta-methoxy polyethylene glycol can be administered once every two weeks or once monthly to patients whose hemoglobin has been stabilized by treatment with an ESA. The dose of epoetin beta-methoxy polyethylene glycol, given as a single IV or subcutaneous injection, should be based on the total weekly ESA dose at the time of conversion.
If the previous weekly epoetin alfa dose was less than 8000 units per week or the previous weekly darbepoetin alfa dose was less than 40 mcg per week, then the epoetin beta-methoxy polyethylene glycol dose would be 120 mcg per month or 60 mcg every two weeks.
If the previous weekly epoetin alfa dose was from 8000 units to 16,000 units per week or the previous weekly darbepoetin alfa dose was from 40 mcg to 80 mcg per week, then the epoetin beta-methoxy polyethylene glycol dose would be 200 mcg per month or 100 mcg every two weeks.
If the previous weekly epoetin alfa dose was greater than 16,000 units per week or the previous weekly darbepoetin alfa dose was greater than 80 mcg per week, then the epoetin beta-methoxy polyethylene glycol dose would be 360 mcg per month or 180 mcg every two weeks.